Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1988 1
1990 1
1991 1
1992 1
1993 6
1994 5
1995 4
1996 1
1998 5
2000 1
2001 3
2002 2
2003 1
2005 1
2006 2
2007 4
2008 2
2009 1
2010 1
2011 3
2012 6
2013 7
2014 3
2015 6
2016 5
2017 1
2018 1
2019 1
2020 2
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
A new era for Advances in Laboratory Medicine.
González Á, Ferrer-Costa R, Fernández-Calle P, Arribas I, Jiménez W. González Á, et al. Among authors: arribas i. Adv Lab Med. 2023 Sep 13;4(3):203-204. doi: 10.1515/almed-2023-0116. eCollection 2023 Sep. Adv Lab Med. 2023. PMID: 38075176 Free PMC article. No abstract available.
Phase II trial of CDK4/6 inhibitor palbociclib in advanced sarcoma based on mRNA expression of CDK4/ CDKN2A.
Martin-Broto J, Martinez-Garcia J, Moura DS, Redondo A, Gutierrez A, Lopez-Pousa A, Martinez-Trufero J, Sevilla I, Diaz-Beveridge R, Solis-Hernandez MP, Carnero A, Perez M, Marcilla D, Garcia-Foncillas J, Romero P, Fernandez-Jara J, Lopez-Lopez D, Arribas I, Hindi N. Martin-Broto J, et al. Among authors: arribas i. Signal Transduct Target Ther. 2023 Oct 25;8(1):405. doi: 10.1038/s41392-023-01661-8. Signal Transduct Target Ther. 2023. PMID: 37875500 Free PMC article. Clinical Trial.
A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors.
Martin-Broto J, Redondo A, Moura DS, Valverde C, Morales JM, Lopez-Pousa A, Martinez-Trufero J, Gutierrez A, Díaz-Beveridge R, Luna P, Martinez-Marin V, Marcilla D, Arribas I, Ledesma P, Lopez-Martin JA, Di Lernia D, Zamora J, Hindi N. Martin-Broto J, et al. Among authors: arribas i. Nat Commun. 2022 Oct 21;13(1):6278. doi: 10.1038/s41467-022-33975-6. Nat Commun. 2022. PMID: 36271011 Free PMC article. Clinical Trial.
B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature.
Arribas I, Maluquer C, Pomares H, Carro I, Baca C, Bosch A, Arévalo CE, Montané C, Ribes-Amorós J, Zamora L, Granada I, Gamundi E, Arnan M, Sureda A. Arribas I, et al. Leuk Lymphoma. 2023 Oct;64(10):1701-1705. doi: 10.1080/10428194.2023.2234527. Epub 2023 Jul 17. Leuk Lymphoma. 2023. PMID: 37455651 Review. No abstract available.
Phosphocalcic metabolism after biliopancreatic diversion.
Lozano O, García-Díaz JD, Cancer E, Arribas I, Rubio JL, González-García I, Galván M, Alvarez J, Martín-Duce A. Lozano O, et al. Among authors: arribas i. Obes Surg. 2007 May;17(5):642-8. doi: 10.1007/s11695-007-9108-0. Obes Surg. 2007. PMID: 17658024
Bisphenol-A induces podocytopathy with proteinuria in mice.
Olea-Herrero N, Arenas MI, Muñóz-Moreno C, Moreno-Gómez-Toledano R, González-Santander M, Arribas I, Bosch RJ. Olea-Herrero N, et al. Among authors: arribas i. J Cell Physiol. 2014 Dec;229(12):2057-66. doi: 10.1002/jcp.24665. J Cell Physiol. 2014. PMID: 24809654 Free article.
75 results